Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union

Gene therapy, cell therapy, and tissue engineering have the potential to revolutionize the treatment of disease and injury. Attaining marketing authorization for such advanced therapy medicinal products (ATMPs) requires a rigorous scientific evaluation by the European Medicines Agency—authorization...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrini, Graziella, Ardigò, Diego, Milazzo, Giovanni, Iotti, Giorgio, Guatelli, Paolo, Pelosi, Danilo, De Luca, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746151/
https://www.ncbi.nlm.nih.gov/pubmed/29280318
http://dx.doi.org/10.1002/sctm.17-0003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746151/
https://www.ncbi.nlm.nih.gov/pubmed/29280318
http://dx.doi.org/10.1002/sctm.17-0003

Ejemplares similares